BeOne Medicines (ONC) News Today $244.32 -0.84 (-0.34%) As of 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsTrendsBuy This Stock ONC Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period This Startup Built A Hospital In India To Test Its AI SoftwareJuly 2 at 2:21 PM | forbes.comBeOne Medicines (NASDAQ:ONC) Given New $330.00 Price Target at Morgan StanleyJune 29 at 2:15 AM | americanbankingnews.comBeOne Medicines (NASDAQ:ONC) Stock Rating Upgraded by Royal Bank Of CanadaJune 29 at 2:15 AM | americanbankingnews.comBeOne Medicines (NASDAQ:ONC) Stock Price Down 3.6% After Insider SellingJune 28, 2025 | americanbankingnews.comBeOne Medicines (NASDAQ:ONC) Shares Gap Down - Time to Sell?June 27, 2025 | marketbeat.comMorgan Stanley Forecasts Strong Price Appreciation for BeOne Medicines (NASDAQ:ONC) StockJune 27, 2025 | marketbeat.comBeOne Medicines (NASDAQ:ONC) Price Target Raised to $321.00June 27, 2025 | marketbeat.comBeOne Medicines (NASDAQ:ONC) Receives "Outperform" Rating from Royal Bank Of CanadaJune 27, 2025 | marketbeat.comBeOne Medicines Ltd.: BeOne Medicines to Host Investor R&D Day Webcast on June 26, 2025 - FinanzNachrichten.deJune 26, 2025 | finanznachrichten.deBeOne Medicines (NASDAQ:ONC) Stock Price Down 3.6% on Insider SellingJune 26, 2025 | marketbeat.comBeOne Medicines Ltd. - Sponsored ADR (NASDAQ:ONC) Insider Lai Wang Sells 1,028 SharesJune 26, 2025 | insidertrades.comLai Wang Sells 1,028 Shares of BeOne Medicines Ltd. - Sponsored ADR (NASDAQ:ONC) StockJune 25, 2025 | marketbeat.comInsider Selling: BeOne Medicines Ltd. - Sponsored ADR (NASDAQ:ONC) COO Sells 1,363 Shares of StockJune 25, 2025 | marketbeat.comInsider Selling: BeOne Medicines Ltd. - Sponsored ADR (NASDAQ:ONC) Insider Sells 2,007 Shares of StockJune 25, 2025 | marketbeat.comBeOne Medicines Ltd. - Sponsored ADR (NASDAQ:ONC) CEO Sells $830,350.14 in StockJune 25, 2025 | marketbeat.comBeOne Medicines Receives Positive CHMP Opinion for Tablet Formulation of BRUKINSA®June 25, 2025 | businesswire.comGlenmark Pharma Launches Lung Cancer Treatment Drug After Approval From AuthoritiesJune 24, 2025 | msn.comBeOne Medicines (NASDAQ:ONC) Shares Gap Up - What's Next?June 23, 2025 | marketbeat.comBeOne Medicines Ltd. - Sponsored ADR (NASDAQ:ONC) SVP Chan Henry Lee Sells 422 SharesJune 19, 2025 | insidertrades.comBeOne Medicines Ltd. - Sponsored ADR (NASDAQ:ONC) Insider Sells $118,143.90 in StockJune 18, 2025 | marketbeat.comInsider Selling: BeOne Medicines Ltd. - Sponsored ADR (NASDAQ:ONC) COO Sells 630 Shares of StockJune 18, 2025 | marketbeat.comInsider Selling: BeOne Medicines Ltd. - Sponsored ADR (NASDAQ:ONC) Insider Sells 1,177 Shares of StockJune 18, 2025 | marketbeat.comBeOne Medicines Ltd. - Sponsored ADR (NASDAQ:ONC) CEO Sells $374,475.40 in StockJune 18, 2025 | marketbeat.comInsider Selling: BeOne Medicines Ltd. - Sponsored ADR (NASDAQ:ONC) COO Sells 1,543 Shares of StockJune 18, 2025 | marketbeat.comJohn Oyler Sells 3,680 Shares of BeOne Medicines Ltd. - Sponsored ADR (NASDAQ:ONC) StockJune 18, 2025 | marketbeat.comBeOne Medicines Ltd. - Sponsored ADR (NASDAQ:ONC) SVP Chan Henry Lee Sells 422 SharesJune 18, 2025 | marketbeat.comBeigene (NASDAQ:ONC) Stock Price Down 5.4% - Should You Sell?June 17, 2025 | marketbeat.comBeigene (NASDAQ:ONC) Shares Gap Down - What's Next?June 16, 2025 | marketbeat.comBeigene, Ltd. (NASDAQ:ONC) Insider Sells $34,620.24 in StockJune 13, 2025 | insidertrades.comBeigene, Ltd. (NASDAQ:ONC) Receives Consensus Rating of "Buy" from AnalystsJune 13, 2025 | marketbeat.comBeigene, Ltd. (NASDAQ:ONC) Insider Sells $34,620.24 in StockJune 12, 2025 | marketbeat.comBeigene, Ltd. (NASDAQ:ONC) Insider Sells $10,975,363.20 in StockJune 12, 2025 | marketbeat.comBeigene (NASDAQ:ONC) Shares Gap Up - Still a Buy?June 12, 2025 | marketbeat.comBeOne Medicines Showcases Breakthrough Data in CLL and MCL at EHA 2025June 12, 2025 | businesswire.comU.S. FDA Approves Tablet Formulation of BeOne's BRUKINSA® for All Approved IndicationsJune 11, 2025 | businesswire.comBeigene, Ltd. (NASDAQ:ONC) SVP Sells $179,277.00 in StockJune 11, 2025 | insidertrades.comBeOne Medicines to Host Investor R&D Day Webcast on June 26, 2025June 11, 2025 | businesswire.comBeigene (NASDAQ:ONC) Shares Down 0.1% on Insider SellingJune 10, 2025 | marketbeat.comInsider Selling: Beigene, Ltd. (NASDAQ:ONC) SVP Sells 700 Shares of StockJune 10, 2025 | marketbeat.comBeigene, Ltd. (NASDAQ:ONC) Insider Lai Wang Sells 1,402 SharesJune 10, 2025 | marketbeat.comBeigene, Ltd. (NASDAQ:ONC) COO Xiaobin Wu Sells 1,934 SharesJune 10, 2025 | marketbeat.comJohn Oyler Sells 5,127 Shares of Beigene, Ltd. (NASDAQ:ONC) StockJune 10, 2025 | marketbeat.comCancer Stock Vaults 40% As Clinical Trial Shows 'Promise'; Sales Reach $1 Billion, Earnings To TripleJune 5, 2025 | investors.comBeOne Medicines Unveils Promising Clinical Data for Two Novel Breast Cancer Therapies at ASCO 2025June 2, 2025 | businesswire.comBeOne Medicines Presents New SEQUOIA Study Results Reinforcing BRUKINSA's Differentiated Profile with or without Venetoclax in Frontline CLL at ASCO 2025May 31, 2025 | businesswire.comBeOne Launches Following Move to SwitzerlandMay 27, 2025 | baystreet.caBeiGene's Tevimbra Gets Positive Opinion from Committee for Medicinal Products for Human UseMay 27, 2025 | marketwatch.comBeiGene Receives Positive CHMP Opinion for TEVIMBRA® as a First-Line Treatment for Nasopharyngeal CancerMay 27, 2025 | finance.yahoo.comBeiGene gets EU backing for neck and head cancer treatmentMay 27, 2025 | msn.comBeOne Medicines Launches Following Redomiciliation to Switzerland, Marking a New Chapter in Global OncologyMay 27, 2025 | businesswire.com Get BeOne Medicines News Delivered to You Automatically Sign up to receive the latest news and ratings for ONC and its competitors with MarketBeat's FREE daily newsletter. Email Address ONC Media Mentions By Week ONC Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ONC News Sentiment▼0.470.90▲Average Medical News Sentiment ONC News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ONC Articles This Week▼237▲ONC Articles Average Week Get BeOne Medicines News Delivered to You Automatically Sign up to receive the latest news and ratings for ONC and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies GSK News TAK News ARGX News BNTX News TEVA News SMMT News ITCI News GMAB News RDY News VTRS News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ONC) was last updated on 7/2/2025 by MarketBeat.com Staff From Our PartnersThe Pentagon just made a National Security move...This "awesome resource" could power America for 30,000 years... We sent one of our smartest researchers.......Stansberry Research | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAI Meltdown Imminent: Dump These Stocks Now!If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new inv...Paradigm Press | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredDalio heeds Buffett’s warning… [$319 million stake in gold]Dalio bought a gold ETF… I don’t recommend that for the average retail investor. The real upside is in profita...Golden Portfolio | SponsoredA new rule goes live in July — and the banks are quietly cashing inA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BeOne Medicines Ltd. - Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share BeOne Medicines With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
